Manufacturing

Pharmaceutical Outsourcing Manufacturing

Contract development and manufacturing companies, or CDMOs, provide a wide range of drug development, formulation and manufacturing services to companies that need outsourcing help to bring pharmaceutical products to market.

Full-service contract development and manufacturing companies can take on every aspect of drug development and manufacturing – many can develop a variety of dosage forms. Specialized CDMOs typically concentrate on one kind of dosage form.

Services offered by contract manufacturing organizations typically include, but are not limited to:

  • Formulation
  • Analytical Services
  • Blending
  • Coating
  • Tableting
  • Parenteral Product R&D and Manufacturing
  • Aseptic Filling
  • Unit Dose Semi-Solids
  • Transdermal Product Development and Manufacturing
  • Topicals
  • Converting
  • Packaging
  • Serialization
  • Shipment

Filter

Hide Filter

  • Equipment Must Integrate

    Wednesday, March 15, 2017
    Modern pharmaceutical manufacturing equipment and associated analytical instrumentation is the fundamental ‘hardware’ required to produce safe, effective, highquality medicinal products. To meet the challenges from increasingly downward price ... read more

  • Advancing Solid Dose Processing Efficiency and Effectiveness

    Wednesday, March 15, 2017
    Because oral solid dose (OSD) pharmaceuticals will remain the dominant dose form, the pharmaceutical industry will continue to be responsible for the high-quality manufacture of hundreds of millions of individual doses every day, every year ... read more

  • Investing for Successful Advancement of Viral Vector Manufacturing

    Wednesday, March 15, 2017
    Gene therapies are designed to treat diseases by modifying genetic information, including correcting genes that function improperly or adding normal copies of defective genes. They have the potential to address and potentially cure a wide range of ... read more

  • Industry Benchmark

    Wednesday, March 15, 2017
    At the heart of That’s Nice is the Nice Insight division, which provides data and analysis from proprietary annual surveys as well as custom primary and secondary research of many kinds. Nice Insight is tasked every year with conducting a series of ... read more

  • Nice Insight: 2017 Industry Leaders

    Wednesday, March 15, 2017
    Nice Insight conducted seven annual studies to survey the pharma landscape and measure what buyers in the market want. These surveys were deployed to respondents in the diverse and dynamic sectors of CDMO, CRO, Equipment, Intermediate, ... read more

  • Spending on Excipients Grows & Diversifies

    Wednesday, March 15, 2017
    Pharmaceutical excipients are used in combination with APIs in multiple medicinal products, including tablets, capsules, oral liquids, transdermal patches, implants and inhalers. Traditionally, these excipients were used to add bulk to ... read more

  • Changes In the Wind for the CDMO Market

    Wednesday, March 15, 2017
    The global pharmaceutical market continues to grow at a healthy rate. According to research firm Evaluate Pharma, the global drug market will expand at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2022, with biologics accounting for ... read more

  • Designing a Better Single-use Facility

    Wednesday, March 15, 2017
    Although single-use, disposable technologies (SUTs) have been around for decades, continued development and implementation of this innovative process technology is needed to help accelerate the advancement of biopharmaceutical drug development. read more

  • Continuous Manufacturing: To Be Continued…

    Wednesday, March 15, 2017
    CONTINUOUS MANUFACTURING OFFERS OBVIOUS ADVANTAGES TO THE PHARMACEUTICAL SECTOR BUT HAS NOT YET EVOLVED INTO A MAJOR ALTERNATIVE TO BATCH. ARE THINGS ABOUT TO CHANGE? read more

  • Next-Generation OSD Manufacturing Strategy

    Wednesday, March 15, 2017
    The Facility of the Future has to be more agile, flexible and efficient than it is today. How to get there? By innovating — introducing new processing concepts, analytics and control — and pulling it together with attention to flow and ergonomics... read more

  • Dissolving Boundaries In Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

    Wednesday, March 15, 2017
    Marken is a leading patient-centric supply chain logistics organization with a complete focus on the pharmaceutical and life-sciences industries. Its state-ofthe- art GMP-compliant network includes 10 GMP-compliant depots and 45 worldwide logistic ... read more

  • Enhancing Responsiveness with Embedded Flexibility

    Wednesday, March 15, 2017
    Responsiveness has always been a key expectation for contract manufacturers providing services to the pharmaceutical industry. Today, however, with increased competition, the growing importance of evidence-based medicine, the expanding focus on ... read more

  • The Data Generation

    Wednesday, March 15, 2017
    The first issue of Pharma’s Almanac in 2017 explores the current market landscape and the impact of Big Data and covers a whole host of other topics: read more

  • Spending on Contract Research Services Slowing Down

    Wednesday, March 15, 2017
    The 2017 Nice Insight Clinical Research Organization (CRO) Outsourcing Survey1 includes input from 608 outsourcing-facing pharmaceutical and biotechnology executives. The majority of the respondents are key decision makers; nearly one-third (31%)... read more

  • There Is Almost No Aspect of the Life Sciences and Related Industries That Big Data Cannot Impact.

    Wednesday, March 15, 2017
    It can help in disease pattern analysis by bringing information together in new ways; it facilitates drug discovery by enabling advanced search capabilities for analyzing millions of publications, patents and clinical trial documents; it can also ... read more
Page